Q2 Results Live Updates: NLC India Profit Doubles; Redington Profit Jumps Over 39%

Power Finance Corporation (Q2, Consolidated YoY)

• Net profit down 2% to Rs 7,682 crore versus Rs 7,834 crore.
• Total income up 1.2% to Rs 29,234 crore versus Rs 28,901 crore.
• Board declared second interim dividend of Rs 4.1/share.

HUDCO (Q2, Consolidated YoY)

• Net profit up 28.3% to Rs 911 crore versus Rs 710 crore.
• Revenue up 24.6% to Rs 4,051 crore versus Rs 3,251 crore.
• Board declared interim dividend of Rs 1.35/share.

Unichem Laboratories (Q2, Consolidated YoY)

• Net profit at Rs 22.2 crore versus loss of Rs 11.9 crore.
• Revenue up 10.6% to Rs 640 crore versus Rs 579 crore.
• Ebitda up 12.5% to Rs 74.5 crore versus Rs 66.2 crore.
• Margin at 11.6% versus 11.4%.

NLC India (Q2, Consolidated YoY)

• Net profit at Rs 1,381 crore versus Rs 665 crore.
• Revenue up 13.3% to Rs 4,732 crore versus Rs 4,178 crore.
• Ebitda down 2.3% to Rs 1,368 crore versus Rs 1,400 crore.
• Margin at 28.9% versus 33.5%.
• Approved fundraising of up to Rs 2,500 crore via bonds.
• Approved OFS of up to 10 crore shares in subsidiary NLC India Renewables.

Redington (Q2, Consolidated YoY)

• Net profit up 39.6% to Rs 541 crore versus Rs 388 crore.
• Revenue up 47.7% to Rs 42,947 crore versus Rs 29,076 crore.
• Ebitda up 42.5% to Rs 839 crore versus Rs 589 crore.
• Margin flat at 2%.

Marksans Pharma (Q2, Consolidated YoY)

• Net profit up 43.4% to Rs 141 crore versus Rs 98.3 crore.
• Revenue up 30.6% to Rs 940 crore versus Rs 720 crore.
• Ebitda up 48.7% to Rs 214.1 crore versus Rs 144 crore.
• Margin at 22.8% versus 20%.

Dr Lal PathLabs (Q2, Consolidated YoY)

• Net profit up 27.6% to Rs 192 crore versus Rs 151 crore.
• Revenue up 19.6% to Rs 874 crore versus Rs 731 crore.
• Ebitda up 25% to Rs 280 crore versus Rs 224 crore.
• Margin at 32.1% versus 30.7%.
• Board declared second interim dividend of Rs 5/share.

Redtape (Q2, Consolidated YoY)

• Net profit up 26.9% to Rs 34.9 crore versus Rs 27.5 crore.
• Revenue down 3.6% to Rs 474.8 crore versus Rs 492.4 crore.
• Ebitda up 61.3% to Rs 74.7 crore versus Rs 46.3 crore.
• Margin at 15.7% versus 9.4%

Exide Industries (Q2, Consolidated YoY)

• Net profit up 66.4% to Rs 286 crore versus Rs 172 crore.
• Revenue up 21.2% to Rs 5,292 crore versus Rs 4,364 crore.
• Ebitda up 43.5% to Rs 562 crore versus Rs 391 crore.
• Margin at 10.6% versus 9%.

Keystone Realtors (Q2, YoY)

Net profit at Rs 100 crore versus Rs 8.6 crore.
Revenue down 0.5% to Rs 497 crore versus Rs 499 crore.
Ebitda at Rs 57.8 crore versus Rs 15.4 crore.
Margin at 11.6% versus 3.1%.

Biocon (Q2, Consolidated YoY)

• Net profit down 51.1% to Rs 41.3 crore versus Rs 84.5 crore. (Estimate: Rs 165 crore)
• Revenue up 2.2% to Rs 4,389 crore versus Rs 4,296 crore. (Estimate: Rs 4,580 crore)
• Ebitda down 0.5% to Rs 831 crore versus Rs 835 crore. (Estimate: Rs 925 crore)
• Margin at 18.9% versus 19.4%. (Estimate: 20.2%)

Hello viewers! This is Khushi and I am back after a slight recess to keep you updated with all the latest earnings on the D-Street. 

• Mrs Bectors Food Specialities reported a 25.2% year-on-year increase in consolidated net profit to Rs 45.7 crore in Q2, compared with Rs 36.5 crore in the year-ago period.
• Revenue grew 14.3% to Rs 631 crore from Rs 551 crore.
• EBITDA increased 19.1% to Rs 82.5 crore from Rs 69.3 crore, while EBITDA margin improved to 13.1% from 12.6%.
   

• Ramco Industries reported a 23.8% year-on-year increase in consolidated net profit to Rs 50.7 crore in Q2, compared with Rs 40.9 crore in the year-ago period.
• Revenue grew 19.1% to Rs 437 crore from Rs 367 crore.
• EBITDA increased 46.7% to Rs 76.9 crore from Rs 52.4 crore, while EBITDA margin improved to 17.6% from 14.3%.

• Zydus Lifesciences reported a 19% year-on-year increase in India formulation sales to Rs 1,884 crore in Q2.
• North America sales grew 20.8% to Rs 3,315 crore, while total international market formulation sales rose 33.2% year-on-year to Rs 1,001 crore.

• Saregama India reported a 47.6% year-on-year increase in consolidated net profit to Rs 64.6 crore in Q2, compared with Rs 43.8 crore in the year-ago period.
• Revenue grew 36.7% to Rs 314 crore from Rs 230 crore.
• EBITDA increased 48.3% to Rs 102 crore from Rs 68.7 crore, while EBITDA margin improved to 32.4% from 29.9%.
• The company will deregister its Dubai-based arm, Saregama FZE.

• Global Health reported a 39.3% year-on-year increase in consolidated net profit to Rs 221 crore in Q2, compared with Rs 158 crore in the year-ago period.
• Revenue grew 33.6% to Rs 1,469 crore from Rs 1,099 crore.
• EBITDA increased 60.3% to Rs 370.1 crore from Rs 230.9 crore, while EBITDA margin improved to 25.2% from 21%.
   

• Cera Sanitaryware reported a marginal 0.9% year-on-year decline in net profit to Rs 56.1 crore in Q2, compared with Rs 56.7 crore in the year-ago period.
• Revenue grew 27.4% to Rs 603 crore from Rs 473 crore.
• EBITDA increased 9.2% to Rs 73.4 crore from Rs 67.2 crore, while EBITDA margin contracted to 12.2% from 14.2%.
• The company reappointed Vikram Somany as Chairman and Managing Director for five years, with the new term effective July 1, 2027.

• ASK Automotive reported a 27.3% year-on-year increase in consolidated net profit to Rs 101.6 crore in Q2, compared with Rs 79.8 crore in the year-ago period.
• Revenue grew 47.6% to Rs 1,555 crore from Rs 1,054 crore.
• EBITDA increased 30.2% to Rs 178.6 crore from Rs 137.2 crore, while EBITDA margin declined to 11.5% from 13%.
   

• Zydus Lifesciences reported a 26.6% year-on-year decline in consolidated net profit to Rs 926 crore in Q2, compared with Rs 1,261 crore in the year-ago period.
• Revenue grew 29% to Rs 7,910 crore from Rs 6,132 crore.
• EBITDA declined 6.4% to Rs 1,895 crore from Rs 2,025 crore, while EBITDA margin contracted to 24% from 33%.

• BASF India reported a 42.4% year-on-year decline in consolidated net profit to Rs 61.7 crore in Q2, compared with Rs 107 crore in the year-ago period.
• Revenue grew 24% to Rs 4,832 crore from Rs 3,896 crore.
• EBITDA declined 40.9% to Rs 91.5 crore from Rs 155 crore, while EBITDA margin contracted to 1.9% from 4%.

• Neuland Labs reported a 46.7% year-on-year decline in consolidated net profit to Rs 51.6 crore in Q2, compared with Rs 96.9 crore in the year-ago period.
• Revenue declined 12.6% to Rs 450 crore from Rs 514 crore.
• EBITDA fell 37.3% to Rs 97.6 crore from Rs 156 crore, while EBITDA margin contracted to 21.7% from 30.2%.
   

Gabriel India reported a 15.4% year-on-year increase in consolidated net profit to Rs 123 crore in Q2, compared with Rs 107 crore in the year-ago period.

Revenue rose 22.9% to Rs 1,608 crore from Rs 1,308 crore, while EBITDA increased 12.2% to Rs 141 crore from Rs 126 crore. EBITDA margin contracted to 8.8% from 9.6%.

The company will pay an interim dividend of Rs 2.15 per share and has fixed November 6 as the record date.

• Vintage Coffee reported a 57.4% year-on-year increase in net profit to Rs 28.1 crore in Q2, compared with Rs 17.8 crore in the year-ago period.
• Revenue rose 64.4% to Rs 223 crore from Rs 136 crore. EBITDA increased 88.7% to Rs 42.2 crore from Rs 22.3 crore, while EBITDA margin expanded to 18.9% from 16.5%.
• Add the quarter and fiscal yearUse consistent crore capitalisation

BSE Limited, Cummins India, Zydus Lifesciences, Apollo Hospitals Enterprises, Lenskart Solutions, Power Finance Corporation, Nykaa, Aurobindo Pharma, NHPC, Dabur India, Torrent Power, Biocon, Sundaram Finance, Balkrishna Industries, Premier Energies, Physicswallah, NLC India, PI Industries, Dr Lal PathLabs, Exide Industries, Apollo Tyres, Garden Reach Shipbuilders & Engineers, Tenneco Clean Air India, Chalet Hotels, Alembic Pharmaceuticals and Kansai Nerolac Paints are among the key earnings announcements to watch as 327 companies report their Q2 FY27 results on Wednesday, November 4.

Follow this live blog for quarterly earnings updates, key financial numbers, management commentary and stock-specific developments.